awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38433407-C1A2E25D-0CB4-4E88-BE12-4320C2512756
Q38433407-C1A2E25D-0CB4-4E88-BE12-4320C2512756
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38433407-C1A2E25D-0CB4-4E88-BE12-4320C2512756
Clinical study of l-asparaginase in the treatment of extranodal NK/T-cell lymphoma, nasal type.
P2860
Q38433407-C1A2E25D-0CB4-4E88-BE12-4320C2512756
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38433407-C1A2E25D-0CB4-4E88-BE12-4320C2512756
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bcae8a5df7f612844fe014188397a3b3ca741bb8
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).